Rintaro Noro

2.7k citations

97 papers · 1.9k · h-index 26

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

Pulmonary and Respiratory Medicine 53
- Lung Cancer Treatments and Mutations 34
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
- Lung Cancer Diagnosis and Treatment 5
Oncology 34
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 5

Co-authors: Akihiko Gemma (76 shared papers)Masahiro Seike (78 shared papers)Yuji Minegishi (44 shared papers)Akihiko Miyanaga (43 shared papers)Kaoru Kubota (48 shared papers)Kuniko Matsuda (25 shared papers)Akinobu Yoshimura (17 shared papers)Tetsuya Okano (15 shared papers)
Journals: OncoTargets and Therapy (6 papers)Anticancer Research (5 papers)Lung Cancer (5 papers)BMC Cancer (5 papers)International Journal of Oncology (5 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Rintaro Noro

95 papers receiving 1.9k citations

Peers

Countries citing papers authored by Rintaro Noro

Since Specialization

Citations

This map shows the geographic impact of Rintaro Noro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rintaro Noro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rintaro Noro more than expected).

Fields of papers citing papers by Rintaro Noro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rintaro Noro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rintaro Noro. The network helps show where Rintaro Noro may publish in the future.

Co-authors

The 25 scholars most cited alongside Rintaro Noro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rintaro Noro Line = papers co-authored together Rintaro Noro links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells Molecular Cancer Therapeutics ·Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, Kuniko Matsuda, Akihiko Miyanaga, Hideaki Mizutani, Rintaro Noro, Yuji Minegishi, Kaoru Kubota, Akihiko Gemma	2013	167
2	MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells International Journal of Oncology ·Mengru Cao, Masahiro Seike, Chie Soeno, Hideaki Mizutani, Kazuhiro Kitamura, Yuji Minegishi, Rintaro Noro, Akinobu Yoshimura, Li Cai, Akihiko Gemma	2012	155
3	Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA) British Journal of Cancer ·Yutaka Kokubo, Akihiko Gemma, Rintaro Noro, Masahiro Seike, Kiyoko Kataoka, Kuniko Matsuda, Testuya Okano, Yuji Minegishi, Akiyo Yoshimura, Masabumi Shibuya, Shoji Kudoh	2005	117
4	Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy Internal Medicine ·Yuji Minegishi, K. Takenaka, Hideki Mizutani, Junko Sudoh, Rintaro Noro, Tetsuya Okano, Arata Azuma, Akinobu Yoshimura, Masahiro Ando, Eitaka Tsuboi, Shoji Kudoh, Akihiko Gemma	2009	109
5	Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model Molecular Cancer Therapeutics ·Akihiko Miyanaga, Akihiko Gemma, Rintaro Noro, Kiyoko Kataoka, Kuniko Matsuda, Michiya Nara, Tetsuya Okano, Masahiro Seike, Akinobu Yoshimura, Akiko Kawakami, Haruka Uesaka, Hiroki Nakae, Shoji Kudoh	2008	88
6	miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells International Journal of Oncology ·Nobuhiko Nishijima, Masahiro Seike, Chie Soeno, Mika Chiba, Akihiko Miyanaga, Rintaro Noro, Teppei Sugano, Masaru Matsumoto, Kaoru Kubota, Akihiko Gemma	2016	63
7	Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer Molecular Cancer Therapeutics ·Teppei Sugano, Masahiro Seike, Rintaro Noro, Chie Soeno, Mika Chiba, Fenfei Zou, Shinji Nakamichi, Nobuhiko Nishijima, Masaru Matsumoto, Akihiko Miyanaga, Kaoru Kubota, Akihiko Gemma	2015	57
8	Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation BMC Cancer ·Rintaro Noro, Akihiko Gemma, Seiji Kosaihira, Yutaka Kokubo, Mingwei Chen, Masahiro Seike, Kiyoko Kataoka, Kuniko Matsuda, Tetsuya Okano, Yuji Minegishi, Akinobu Yoshimura, Shoji Kudoh	2006	54
9	PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors International Journal of Oncology ·Shoji Kudoh, Akinobu Yoshimura, Kiyoko Kataoka, Kuniko Matsuda, Tetsuya Okano, Masahiro Seike, Yutaka Kokubo, Michiya Nara, Yuji Minegishi, Seiji Kosaihira, Akihiko Miyanaga, Akihiko Gemma, Rintaro Noro	2007	48
10	Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study Cancer Epidemiology Biomarkers & Prevention ·Majda Haznadar, Qiuyin Cai, Kristopher W. Krausz, Elise D. Bowman, Ezra Margono, Rintaro Noro, Matthew D. Thompson, Ewy A. Mathé, Heather M. Munro, Mark Steinwandel, Frank J. Gonzalez, William J. Blot, Curtis C. Harris	2016	47
11	Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells Thoracic Cancer ·Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda, Natsuki Takano, Satoshi Takahashi, Rintaro Noro, Akihiko Gemma	2021	46
12	Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation BMC Cancer ·Akihiko Miyanaga, K Shimizu, Rintaro Noro, Masahiro Seike, Kazuhiro Kitamura, Seiji Kosaihira, Yuji Minegishi, Takehito Shukuya, Akinobu Yoshimura, Masashi Kawamoto, Shin‐ichi Tsuchiya, Koichi Hagiwara, Manabu Soda, Kengo Takeuchi, Nobuyuki Yamamoto, Hiroyuki Mano, Yuichi Ishikawa, Akihiko Gemma	2013	45
13	Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer Scientific Reports ·Akiko Takahashi, Masahiro Seike, Mika Chiba, Satoshi Takahashi, Shinji Nakamichi, Masaru Matsumoto, Susumu Takeuchi, Yuji Minegishi, Rintaro Noro, Shinobu Kunugi, Kaoru Kubota, Akihiko Gemma	2018	44
14	Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion Cancer Chemotherapy and Pharmacology ·Kazuhiro Kitamura, Kaoru Kubota, Masahiro Ando, Satoshi Takahashi, Nobuhiko Nishijima, Teppei Sugano, Masaru Toyokawa, Koji Miwa, Seiji Kosaihira, Rintaro Noro, Yuji Minegishi, Masahiro Seike, Akinobu Yoshimura, Akihiko Gemma	2012	44
15	Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer Thoracic Cancer ·Teppei Sugano, Masahiro Seike, Yoshinobu Saito, Takeru Kashiwada, Yasuhiro Terasaki, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Toru Tanaka, Susumu Takeuchi, Akihiko Miyanaga, Yuji Minegishi, Rintaro Noro, Kaoru Kubota, Akihiko Gemma	2020	40
16	Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database BMC Cancer ·Akihiko Gemma, Li Cai, Yuka Sugiyama, Kuniko Matsuda, Yoko Seike, Seiji Kosaihira, Yuji Minegishi, Rintaro Noro, Michiya Nara, Masahiro Seike, Akinobu Yoshimura, Aki Shionoya, Akiko Kawakami, Naoki Ogawa, Haruka Uesaka, Shoji Kudoh	2006	40
17	Histone deacetylase inhibitor enhances sensitivity of non‐small‐cell lung cancer cells to 5‐FU/S‐1 via down‐regulation of thymidylate synthase expression and up‐regulation of p21 ^waf1/cip1 expression Cancer Science ·Rintaro Noro, Akihiko Miyanaga, Yuji Minegishi, Tetsuya Okano, Masahiro Seike, Chie Soeno, Kiyoko Kataoka, Kuniko Matsuda, Akinobu Yoshimura, Akihiko Gemma	2010	38
18	miR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma Oncology Reports ·Kazuo Yamamoto, Masahiro Seike, Susumu Takeuchi, Chie Soeno, Akihiko Miyanaga, Rintaro Noro, Yuji Minegishi, Kaoru Kubota, Akihiko Gemma	2014	37
19	Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification Annals of Oncology ·Rintaro Noro, Kazufumi Honda, K. Tsuta, Genichiro Ishii, Arafumi Maeshima, Naoko Miura, Koh Furuta, Tatsuhiro Shibata, Hitoshi Tsuda, Atsushi Ochiai, Tomohiro Sakuma, Nobuhiko Nishijima, Akihiko Gemma, Hisao Asamura, Kanji Nagai, Tesshi Yamada	2013	34
20	Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema Lung Cancer ·Yuji Minegishi, Nariaki Kokuho, Yukiko Miura, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Yoshinobu Saito, Masahiro Seike, Kaoru Kubota, Arata Azuma, Kouzui Kida, Akihiko Gemma	2014	32

About Rintaro Noro

Rintaro Noro is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 97 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Lung Cancer Research Studies (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (449 citations), Pulmonary and Respiratory Medicine (711 citations), Oncology (582 citations), Molecular Biology (881 citations) and Pathology and Forensic Medicine (74 citations). Rintaro Noro has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Akihiko Gemma, Masahiro Seike, Yuji Minegishi, Akihiko Miyanaga, Kaoru Kubota, Kuniko Matsuda, Akinobu Yoshimura, Tetsuya Okano, Kazuhiro Kitamura and Chie Soeno. Their work appears in journals such as OncoTargets and Therapy, Anticancer Research, Lung Cancer, BMC Cancer and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rintaro Noro

Impact in

Papers in i

In The Last Decade

Rintaro Noro

Peers

Countries citing papers authored by Rintaro Noro

Fields of papers citing papers by Rintaro Noro

All Works

About Rintaro Noro

Explore authors with similar magnitude of impact

Papers in